Clinical trial
Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant…
NCT00170053 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00170053 |
|---|---|
| Title | Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids |
| Official title | Randomized Trial of Thymoglobulin Induction, Initial Tacrolimus, and Mycophenolate Mofetil Therapy With Steroid Avoidance in Primary Kidney Transplant Recipients Followed by Continued Tacrolimus/Mycophenolate Mofetil Therapy vs. Sirolimus/ Mycophenolate Mofetil Therapy |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry Genzyme, a Sanofi Company Raymond Heilman |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Diseases |
| Intervention type | Drug |
| Interventions | Sirolimus |
| Enrollment | 177 |
| Start date | Jun 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 31, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: